Home  »  Trending   »  Radius Health Inc. (RDUS): Skating on Thin Ice? We...

Radius Health Inc. (RDUS): Skating on Thin Ice? We Know the Answer

Radius Health Inc. (NASDAQ:RDUS) went up by 0.20% from its latest closing price compared to the recent 1-year high of $23.00. The company’s stock price has collected 0.40% of gains in the last five trading sessions.

Is It Worth Investing in Radius Health Inc. (NASDAQ :RDUS) Right Now?

Plus, the 36-month beta value for RDUS is at 0.53. Opinions of the stock are interesting as 0 analysts out of 4 who provided ratings for Radius Health Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 4 rated it as “hold,” and 0 as “sell.”

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


The average price from analysts is $10.00, which is -$0.51 below the current price. RDUS currently public float of 47.35M and currently shorts hold a 6.46% ratio of that float. Today, the average trading volume of RDUS was 1.26M shares.

RDUS’s Market Performance

RDUS stocks went up by 0.40% for the week, with a monthly drop of -3.90% and a quarterly performance of 41.60%, while its annual performance rate touched -29.35%. The volatility ratio for the week stands at 0.46% while the volatility levels for the past 30 days are set at 1.43% for Radius Health Inc. The simple moving average for the period of the last 20 days is -0.05% for RDUS stocks with a simple moving average of 3.57% for the last 200 days.

Analysts’ Opinion of RDUS

Many brokerage firms have already submitted their reports for RDUS stocks, with BofA Securities repeating the rating for RDUS by listing it as a “Neutral.” The predicted price for RDUS in the upcoming period, according to BofA Securities is $8 based on the research report published on June 08th of the current year 2022.

SVB Leerink, on the other hand, stated in their research note that they expect to see RDUS reach a price target of $7. The rating they have provided for RDUS stocks is “Mkt Perform” according to the report published on May 23rd, 2022.

Morgan Stanley gave a rating of “Underweight” to RDUS, setting the target price at $7 in the report published on December 10th of the previous year.

RDUS Trading at 13.91% from the 50-Day Moving Average

After a stumble in the market that brought RDUS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -56.04% of loss for the given period.

Volatility was left at 1.43%, however, over the last 30 days, the volatility rate increased by 0.46%, as shares sank -1.27% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +67.38% upper at present.

During the last 5 trading sessions, RDUS rose by +0.40%, which changed the moving average for the period of 200-days by -36.65% in comparison to the 20-day moving average, which settled at $10.11. In addition, Radius Health Inc. saw 46.10% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at RDUS starting from BIOTECH TARGET N V, who purchase 477,824 shares at the price of $5.57 back on May 18. After this action, BIOTECH TARGET N V now owns 8,733,538 shares of Radius Health Inc., valued at $2,661,002 using the latest closing price.

BIOTECH TARGET N V, the 10% Owner of Radius Health Inc., purchase 300,000 shares at $6.31 during a trade that took place back on Jan 06, which means that BIOTECH TARGET N V is holding 8,255,714 shares at $1,894,410 based on the most recent closing price.

Stock Fundamentals for RDUS

Current profitability levels for the company are sitting at:

  • -23.62 for the present operating margin
  • +91.52 for the gross margin

The net margin for Radius Health Inc. stands at -30.51. Equity return is now at value 29.40, with -40.70 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 1.83.